share_log

Invivyd | CORRESP: CORRESP

Invivyd | CORRESP: CORRESP

Invivyd | CORRESP:信函
美股SEC公告 ·  04/19 02:09

Moomoo AI 已提取核心信息

Invivyd, Inc., a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on February 9, 2024. The company seeks to have the Registration Statement declared effective by 4:00 p.m. Eastern Time on April 19, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933. Invivyd's Chief Legal Officer and Corporate Secretary, Jill Andersen, signed the request, and any inquiries or communications regarding this acceleration are to be directed to Stephen M. Nicolai of Hogan Lovells US LLP.
Invivyd, Inc., a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on February 9, 2024. The company seeks to have the Registration Statement declared effective by 4:00 p.m. Eastern Time on April 19, 2024. This request was made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933. Invivyd's Chief Legal Officer and Corporate Secretary, Jill Andersen, signed the request, and any inquiries or communications regarding this acceleration are to be directed to Stephen M. Nicolai of Hogan Lovells US LLP.
生物技术公司Invivyd, Inc. 已正式要求美国证券交易委员会(SEC)加快其最初于2024年2月9日提交的S-3表格注册声明的生效日期。该公司希望在东部时间2024年4月19日下午4点之前宣布注册声明生效。该请求是根据1933年《证券法》下的《一般规则和条例》第461条提出的。Invivyd的首席法务官兼公司秘书吉尔·安德森签署了该请求,有关加速的任何询问或沟通都将发送给霍根·洛弗尔斯美国律师事务所的斯蒂芬·尼古拉。
生物技术公司Invivyd, Inc. 已正式要求美国证券交易委员会(SEC)加快其最初于2024年2月9日提交的S-3表格注册声明的生效日期。该公司希望在东部时间2024年4月19日下午4点之前宣布注册声明生效。该请求是根据1933年《证券法》下的《一般规则和条例》第461条提出的。Invivyd的首席法务官兼公司秘书吉尔·安德森签署了该请求,有关加速的任何询问或沟通都将发送给霍根·洛弗尔斯美国律师事务所的斯蒂芬·尼古拉。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息